The data on Pfizer's GLP-1 offer early evidence that the injection can be administered less frequently than existing drugs ...
A single subcutaneous injection of the investigational drug zilebesiran, when added to existing treatment with a standard antihypertensive medication, reduced systolic blood pressure by between 4 to ...
Please provide your email address to receive an email when new articles are posted on . FORT LAUDERDALE, Fla. — In this Healio Video Perspective, Michael A. Singer, MD, discusses promising results for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results